Sarcoidosis is not associated with BRAFV600E mutation

References

• Adam, A., Thomas, L., Bories, N., Zaharia, D., Balme, B., Freymond, N., & Dalle, S. (2013). Sarcoidosis associated with vemurafenib. British Journal of Dermatology, 169, 206–208.10.1111/bjd.2013.169.issue-1
   PubMed Web of Science ®Google Scholar
• Andrulis, M., Penzel, R., Weichert, W., von Deimling, A., & Capper, D. (2012). Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia. The American Journal of Surgical Pathology, 36, 1796–1800.10.1097/PAS.0b013e3182549b50
   PubMed Web of Science ®Google Scholar
• Badalian-Very, G., Vergilio, J. A., Degar, B. A., MacConaill, L. E., Brandner, B., Calicchio, M. L., … Rollins, B. J. (2010). Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood, 116, 1919–1923.10.1182/blood-2010-04-279083
   PubMed Web of Science ®Google Scholar
• Bergeron, A., Bonay, M., Kambouchner, M., Lecossier, D., Riquet, M., Soler, P., … Tazi, A. (1997). Cytokine patterns in tuberculous and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response. Journal of Immunology, 159, 3034–3043.
   PubMed Web of Science ®Google Scholar
• Berghoff, A. S., & Preusser, M. (2014). Braf alterations in brain tumours: Molecular pathology and therapeutic opportunities. Current opinion in neurology, 27, 689–696.
   PubMed Web of Science ®Google Scholar
• Berres, M. L., Allen, C. E., & Merad, M. (2013). Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases. Advances in Immunology, 120, 127–161.10.1016/B978-0-12-417028-5.00005-3
   PubMed Web of Science ®Google Scholar
• Berres, M. L., Lim, K. P., Peters, T., Price, J., Takizawa, H., Salmon, H., … Allen, C. E. (2014). BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. The Journal of Experimental Medicine, 211, 669–683.10.1084/jem.20130977
   PubMed Web of Science ®Google Scholar
• Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., … Nolop, K. (2010). Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature, 467, 596–599.10.1038/nature09454
   PubMed Web of Science ®Google Scholar
• Chilosi, M., Facchetti, F., Caliò, A., Zamò, A., Brunelli, M., Martignoni, G., … Doglioni, C. (2014). Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leukemia & Lymphoma, 55, 2620–2626.10.3109/10428194.2014.887713
   PubMed Web of Science ®Google Scholar
• Dietrich, S., Glimm, H., Andrulis, M., von Kalle, C., Ho, A. D., & Zenz, T. (2012). BRAF inhibition in refractory hairy-cell leukemia. New England Journal of Medicine, 366, 2038–2040.10.1056/NEJMc1202124
   PubMed Web of Science ®Google Scholar
• Fedoriw, Y., Kim, Y., Vergilio, J., Chen, Z., Weiss, L., & O’Malley, D. (2014). Braf v600e mutation-specific immunohistochemistry is a rare finding in dendritic cell and histiocyte-derived tumors. Leuk Lymphoma, 1–6.
   Web of Science ®Google Scholar
• Go, H., Jeon, Y. K., Huh, J., Choi, S. J., Choi, Y. D., Cha, H. J., … Kim, J. E. (2014). Frequent detection of braf mutations in histiocytic and dendritic cell neoplasms. Histopathology, 65, 261–272.
   PubMed Web of Science ®Google Scholar
• Haroche, J., Charlotte, F., Arnaud, L., von Deimling, A., Helias-Rodzewicz, Z., Hervier, B., … Emile, J. F. (2012). High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood, 120, 2700–2703.10.1182/blood-2012-05-430140
   PubMed Web of Science ®Google Scholar
• Haroche, J., Cohen-Aubart, F., Emile, J. F., Arnaud, L., Maksud, P., Charlotte, F., … Amoura, Z. (2013). Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood, 121, 1495–1500.10.1182/blood-2012-07-446286
   PubMed Web of Science ®Google Scholar
• Hervier, B., Haroche, J., Arnaud, L., Charlotte, F., Donadieu, J., Neel, A., … Rigolet, A. (2014). Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood, 124, 1119–1126.10.1182/blood-2013-12-543793
   PubMed Web of Science ®Google Scholar
• Iannuzzi, M. C., Rybicki, B. A., & Teirstein, A. S. (2007). Sarcoidosis. New England Journal of Medicine, 357, 2153–2165.10.1056/NEJMra071714
   PubMed Web of Science ®Google Scholar
• Ma, Y., Gal, A., & Koss, M. N. (2007). The pathology of pulmonary sarcoidosis: Update. Seminars in Diagnostic Pathology, 24, 150–161.10.1053/j.semdp.2007.06.002
   PubMed Web of Science ®Google Scholar
• Machnicki, M. M., & Stoklosa, T. (2014). Braf—A new player in hematological neoplasms. Blood Cells Mol Dis, 53, 77–83.
   PubMed Web of Science ®Google Scholar
• Rastogi, R., Du, W., Ju, D., Pirockinaite, G., Liu, Y., Nunez, G., & Samavati, L. (2011). Dysregulation of p38 and MKP-1 in Response to NOD1/TLR4 stimulation in sarcoid bronchoalveolar cells. American Journal of Respiratory and Critical Care Medicine, 183, 500–510.10.1164/rccm.201005-0792OC
   PubMed Web of Science ®Google Scholar
• Roden, A. C., Hu, X., Kip, S., Parrilla Castellar, E. R., Rumilla, K. M., Vrana, J. A., … Yi, E. S. (2014). Braf v600e expression in langerhans cell histiocytosis: Clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. The American Journal of Surgical Pathology, 38, 548–551.10.1097/PAS.0000000000000129
   PubMed Web of Science ®Google Scholar
• Sahm, F., Capper, D., Preusser, M., Meyer, J., Stenzinger, A., Lasitschka, F., … von Deimling, A. (2012). BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood, 120, e28–e34.10.1182/blood-2012-06-429597
   PubMed Web of Science ®Google Scholar
• Satoh, T., Smith, A., Sarde, A., Lu, H. C., Mian, S., Trouillet, C., … Geissmann, F. (2012). B-RAF mutant alleles associated with langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS One, 7, e33891.10.1371/journal.pone.0033891
   PubMed Web of Science ®Google Scholar
• Wilgenhof, S., Morlion, V., Seghers, A. C., Du Four, S., Vanderlinden, E., Hanon, S., … Neyns, B. (2012). Sarcoidosis in a patient with metastatic melanoma sequentially treated with anti-ctla-4 monoclonal antibody and selective braf inhibitor. Anticancer Research, 32, 1355–1359.
   PubMed Web of Science ®Google Scholar
• Yousem, S. A., Dacic, S., Nikiforov, Y. E., & Nikiforova, M. (2013). Pulmonary langerhans cell histiocytosis: Profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of braf v600e mutations. Chest, 143, 1679–1684.
   PubMed Web of Science ®Google Scholar